Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

EEG alpha power as an intermediate measure between brain-derived neurotrophic factor Val66Met and depression severity in patients with major depressive disorder.

Zoon HF, Veth CP, Arns M, Drinkenburg WH, Talloen W, Peeters PJ, Kenemans JL.

J Clin Neurophysiol. 2013 Jun;30(3):261-7. doi: 10.1097/WNP.0b013e3182933d6e.

PMID:
23733090
2.

Association between BDNF Val66Met polymorphism and trait depression is mediated via resting EEG alpha band activity.

Gatt JM, Kuan SA, Dobson-Stone C, Paul RH, Joffe RT, Kemp AH, Gordon E, Schofield PR, Williams LM.

Biol Psychol. 2008 Oct;79(2):275-84. doi: 10.1016/j.biopsycho.2008.07.004. Epub 2008 Jul 31.

PMID:
18721847
3.

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

Frodl T, Schüle C, Schmitt G, Born C, Baghai T, Zill P, Bottlender R, Rupprecht R, Bondy B, Reiser M, Möller HJ, Meisenzahl EM.

Arch Gen Psychiatry. 2007 Apr;64(4):410-6.

PMID:
17404118
4.

Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity.

Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, Buitelaar JK, Franke B.

Mol Psychiatry. 2010 Mar;15(3):260-71. doi: 10.1038/mp.2008.109. Epub 2008 Oct 14.

PMID:
18852698
5.

Association between C-281A and val66met functional polymorphisms of BDNF gene and risk of recurrent major depressive disorder in Polish population.

Suchanek R, Owczarek A, Kowalczyk M, Kucia K, Kowalski J.

J Mol Neurosci. 2011 Mar;43(3):524-30. doi: 10.1007/s12031-010-9478-y. Epub 2010 Nov 20.

PMID:
21103954
6.

Association of BDNF Val66Met polymorphism with both baseline HRQOL scores and improvement in HRQOL scores in Chinese major depressive patients treated with fluoxetine.

Zou YF, Wang Y, Liu P, Feng XL, Wang BY, Zang TH, Yu X, Wei J, Liu ZC, Liu Y, Tao M, Li HC, Li KQ, Hu J, Li M, Zhang KR, Ye DQ, Xu XP.

Hum Psychopharmacol. 2010 Mar;25(2):145-52. doi: 10.1002/hup.1099.

PMID:
20196181
7.

Reduced fractional anisotropy in the uncinate fasciculus in patients with major depression carrying the met-allele of the Val66Met brain-derived neurotrophic factor genotype.

Carballedo A, Amico F, Ugwu I, Fagan AJ, Fahey C, Morris D, Meaney JF, Leemans A, Frodl T.

Am J Med Genet B Neuropsychiatr Genet. 2012 Jul;159B(5):537-48. doi: 10.1002/ajmg.b.32060. Epub 2012 May 14.

PMID:
22585743
8.

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.

Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM.

Neurobiol Aging. 2006 Dec;27(12):1834-7. Epub 2005 Dec 15.

PMID:
16343697
9.

Interaction between brain-derived neurotrophic factor Val66Met polymorphism and recent negative stressor in harm avoidance.

Kim SJ, Cho SJ, Jang HM, Shin J, Park PW, Lee YJ, Cho IH, Choi JE, Lee HJ.

Neuropsychobiology. 2010;61(1):19-26. doi: 10.1159/000258639. Epub 2009 Nov 13.

PMID:
19923862
10.

Serum levels of brain-derived neurotrophic factor (BDNF), BDNF gene Val66Met polymorphism, or plasma catecholamine metabolites, and response to mirtazapine in Japanese patients with major depressive disorder (MDD).

Katsuki A, Yoshimura R, Kishi T, Hori H, Umene-Nakano W, Ikenouchi-Sugita A, Hayashi K, Atake K, Iwata N, Nakamura J.

CNS Spectr. 2012 Sep;17(3):155-63. doi: 10.1017/S109285291200051X. Epub 2012 Aug 10.

PMID:
22883353
11.

Analysis of genetic polymorphisms of brain-derived neurotrophic factor and methylenetetrahydrofolate reductase in depressed patients in a Slovak (Caucasian) population.

Evinova A, Babusikova E, Straka S, Ondrejka I, Lehotsky J.

Gen Physiol Biophys. 2012 Dec;31(4):415-22. doi: 10.4149/gpb_2012_049.

PMID:
23255668
12.

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

Borroni B, Archetti S, Costanzi C, Grassi M, Ferrari M, Radeghieri A, Caimi L, Caltagirone C, Di Luca M, Padovani A; ITINAD Working Group.

Neurobiol Aging. 2009 Sep;30(9):1406-12. doi: 10.1016/j.neurobiolaging.2007.11.023. Epub 2008 Jan 7.

PMID:
18179845
13.

Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder.

Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS.

Brain Res. 2006 Nov 6;1118(1):176-82. Epub 2006 Sep 18.

PMID:
16979146
14.

[Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression].

Rajewska-Rager A, Skibińska M, Szczepankiewicz A, Kapelski P, Dmitrzak-Weglarz M, Leszczyńska-Rodziewicz A, Hauser J.

Psychiatr Pol. 2008 Nov-Dec;42(6):915-23. Polish.

PMID:
19441668
15.

Impact of variation in the BDNF gene on social stress sensitivity and the buffering impact of positive emotions: replication and extension of a gene-environment interaction.

van Winkel M, Peeters F, van Winkel R, Kenis G, Collip D, Geschwind N, Jacobs N, Derom C, Thiery E, van Os J, Myin-Germeys I, Wichers M.

Eur Neuropsychopharmacol. 2014 Jun;24(6):930-8. doi: 10.1016/j.euroneuro.2014.02.005. Epub 2014 Feb 18.

16.

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder.

Zou YF, Ye DQ, Feng XL, Su H, Pan FM, Liao FF.

Eur Neuropsychopharmacol. 2010 Aug;20(8):535-44. doi: 10.1016/j.euroneuro.2009.12.005. Epub 2010 Feb 18.

PMID:
20167454
17.

The BDNF Val66Met polymorphism predicts rumination and depression differently in young adolescent girls and their mothers.

Hilt LM, Sander LC, Nolen-Hoeksema S, Simen AA.

Neurosci Lett. 2007 Dec 11;429(1):12-6. Epub 2007 Oct 2.

PMID:
17959306
18.

No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Musil R, Zill P, Seemüller F, Bondy B, Obermeier M, Spellmann I, Bender W, Adli M, Heuser I, Zeiler J, Gaebel W, Maier W, Rietschel M, Rujescu D, Schennach R, Möller HJ, Riedel M.

Eur Arch Psychiatry Clin Neurosci. 2013 Aug;263(5):405-12. doi: 10.1007/s00406-012-0364-1. Epub 2012 Sep 11.

PMID:
22965830
19.

Childhood adversity interacts separately with 5-HTTLPR and BDNF to predict lifetime depression diagnosis.

Carver CS, Johnson SL, Joormann J, Lemoult J, Cuccaro ML.

J Affect Disord. 2011 Jul;132(1-2):89-93. doi: 10.1016/j.jad.2011.02.001. Epub 2011 Mar 21.

PMID:
21420735
20.

Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.

Aguilera M, Arias B, Wichers M, Barrantes-Vidal N, Moya J, Villa H, van Os J, Ibáñez MI, Ruipérez MA, Ortet G, Fañanás L.

Psychol Med. 2009 Sep;39(9):1425-32. doi: 10.1017/S0033291709005248. Epub 2009 Feb 12.

PMID:
19215635

Supplemental Content

Support Center